Eos publishes their proof of concept work in Molecular Therapy
04-19-11
Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness
M Mehdi Doroudchi, Kenneth P Greenberg, Jianwen Liu, Kimberly A Silka, Edward S Boyden, Jennifer A Lockridge, A ... Read More
Eos CSO Alan Horsager Interviewed by New Scientist
04-14-11
BLIND people could one day have their sight restored thanks to a treatment that borrows a gene from an unlikely source - algae - and inserts it into the retina. The technique has succeeded in restoring the ability to sense light and dark to bli... Read More
Eos CSO Alan Horsager and Ed Boyden interviewed by Reuters
03-18-11
U.S. scientists who have successfully restored sight to blind lab mice say their experiments in the field of optogenetics could one day be used to treat - and possibly cure - neurological disorders such as Parkinson's and Alzheimer's diseases. Ben Gr... Read More
CEO Ben Matteo on CNN Headline News
01-03-10
Eos Neuroscience CEO Ben Matteo is interviewed on CNN Headline News by anchor Holly Firfer.... Read More
Welcome to Eos Neuroscience. We are developing novel treatments for blindness and other serious neurological conditions using optogenetic and gene therapy approaches.
